We are live on ! Find out more
ARCT icon

Arcturus Therapeutics
ARCT

170 hedge funds and large institutions have $640M invested in Arcturus Therapeutics in 2024 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 45 increasing their positions, 65 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more call options, than puts

Call options by funds: $9.61M | Put options by funds: $4.35M

3.57% less ownership

Funds ownership: 101.13% → 97.57% (-3.6%)

5% less funds holding

Funds holding: 179 → 170 (-9)

15% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 40

30% less capital invested

Capital invested by funds: $919M → $640M (-$279M)

31% less repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 65

Holders
170
Holders Change
-9
Holders Change %
-5.03%
% of All Funds
2.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
34
Increased
45
Reduced
65
Closed
40
Calls
$9.61M
Puts
$4.35M
Net Calls
+$5.26M
Net Calls Change
+$5.34M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$12M
2
NAMA
Nikko Asset Management Americas
New York
+$8.69M
3
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
+$8.69M
4
AIM
ARK Investment Management
Florida
+$8.35M
5
PCM
Portolan Capital Management
Massachusetts
+$7.29M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$15.2M
2
State Street
State Street
Massachusetts
-$13.2M
3
GLA
Great Lakes Advisors
Illinois
-$7.1M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$5.63M
5
WP
Woodline Partners
California
-$4.86M
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
26
Baker Bros. Advisors
New York
$3.68M +$4.59M +151,329 New
RA
27
Royce & Associates
New York
$3.21M – – –
Bank of America
28
Bank of America
North Carolina
$3.17M -$2.08M -68,496 -34%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$2.9M +$109K +3,578 +3%
American Century Companies
30
American Century Companies
Missouri
$2.48M -$3.93M -129,706 -56%
Jacobs Levy Equity Management
31
Jacobs Levy Equity Management
New Jersey
$2.44M +$134K +4,412 +5%
N
32
Nuveen
North Carolina
$2.18M -$1.04M -34,222 -28%
Rafferty Asset Management
33
Rafferty Asset Management
New York
$1.9M -$2.38M -78,579 -50%
Connor, Clark & Lunn Investment Management (CC&L)
34
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.82M -$1.25M -41,115 -35%
Jane Street
35
Jane Street
New York
$1.78M +$767K +25,295 +53%
Wells Fargo
36
Wells Fargo
California
$1.77M +$34.2K +1,128 +2%
Franklin Resources
37
Franklin Resources
California
$1.64M -$104K -3,424 -5%
Nordea Investment Management
38
Nordea Investment Management
Sweden
$1.62M +$319K +10,535 +19%
HCA
39
Harbor Capital Advisors
Illinois
$1.6M +$1.51M +49,709 +311%
State of Wisconsin Investment Board
40
State of Wisconsin Investment Board
Wisconsin
$1.55M +$214K +7,047 +12%
UBS Group
41
UBS Group
Switzerland
$1.51M -$1.39M -45,780 -42%
GCP
42
GSA Capital Partners
United Kingdom
$1.5M +$1.87M +61,630 New
TI
43
Trexquant Investment
Connecticut
$1.3M +$1.62M +53,409 New
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
$1.18M +$824K +27,183 +127%
Swiss National Bank
45
Swiss National Bank
Switzerland
$1.16M +$15.2K +500 +1%
Marshall Wace
46
Marshall Wace
United Kingdom
$1.1M -$1.18M -39,048 -46%
DekaBank Deutsche Girozentrale
47
DekaBank Deutsche Girozentrale
Germany
$1.07M – – –
Barclays
48
Barclays
United Kingdom
$1.06M +$235K +7,757 +22%
Balyasny Asset Management
49
Balyasny Asset Management
Illinois
$1.02M +$1.27M +41,947 New
QC
50
Quantedge Capital
Singapore
$993K -$282K -9,300 -19%
1
2
3 4 5

ARCT Hedge Fund Activity: Q2 2024 in Review

170 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q2 2024, worth a combined $640M — down 30% from $919M a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of ARCT and 34 opened new positions — a net loss of 6 holders — while 65 trimmed existing stakes and 45 added.

The largest buyer was Millennium Management, adding an estimated $12M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $15.2M sold.

  • 170 institutional investors held Arcturus Therapeutics (ARCT) as of Q2 2024, down from 179 in Q1 2024.
  • Funds reported $640M of Arcturus Therapeutics stock for Q2 2024, down 30% quarter-over-quarter.
  • 34 funds opened new Arcturus Therapeutics positions in Q2 2024 and 40 closed out, a net change of -6 holders.
  • The largest Arcturus Therapeutics buyer in Q2 2024 was Millennium Management, an estimated $12M added.
  • The largest Arcturus Therapeutics seller in Q2 2024 was Adage Capital Partners, an estimated $15.2M sold.

Based on aggregated 13F filings for Q2 2024.